This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cao, L. Articles by Gardner, D. G. Search for Related Content PubMed PubMed Citation Articles by Cao, L. Articles by Gardner, D. G.

Hypertension, Vol 24, 329-338, Copyright © 1994 by American Heart Association

ARTICLES

Differential regulation of natriuretic peptide receptor activity in vascular cells

L Cao, DW Zlock and DG Gardner
Metabolic Research Unit, University of California at San Francisco 94143.

We studied the regulation of the individual natriuretic peptide receptor subtypes by 12-O-tetradecanoylphorbol 13-acetate (TPA) and forskolin in cultured bovine aortic endothelial and smooth muscle cells. In cultured endothelial cells, 10(-8) mol/L TPA caused a reduction in atrial natriuretic peptide (ANP) receptor binding activity that was seen as early as 2 hours after the treatment and reached a maximum (88 +/- 3% of control) after 24 hours, whereas the inhibition of ANP-stimulated cyclic GMP (cGMP) accumulation peaked at 2 hours (62 +/- 13% of control) and returned to control levels after 12 hours. After 24 hours of forskolin (10(-4) mol/L) treatment, ANP binding activity fell to 47 +/- 6%, and cGMP accumulation was 52 +/- 11% of control. Northern blot analysis revealed that 10(-8) mol/L TPA suppressed natriuretic peptide C receptor transcript levels, and forskolin increased levels modestly after 24 hours of treatment. Natriuretic peptide A receptor transcript levels remained unchanged by either treatment. In cultured smooth muscle cells, 10(-8) mol/L TPA suppressed ANP binding activity and ANP-stimulated cGMP formation in a fashion similar to that seen in endothelial cells. TPA treatment also resulted in an inhibition of C-type natriuretic peptide-stimulated cGMP production (59 +/- 7% of control); however, this response persisted for as long as 24 hours after addition of the agonist. Treatment with 10(- 4) mol/L forskolin produced a time-dependent inhibition of ANP binding activity and did not inhibit cGMP production stimulated by either ANP or C-type natriuretic peptide. In contrast to the effects seen with endothelial cells, TPA caused a dose-dependent stimulation of natriuretic peptide C receptor mRNA, whereas forskolin was inhibitory in smooth muscle cells. These results indicate that the effects of the kinase activators are a function of the individual receptor subtype as well as the cell in which it is expressed and imply a considerable degree of flexibility in the response to regulatory stimuli.

This article has been cited by other articles:

				Q. Ye, S. Chen, and D. G. Gardner Endothelin Inhibits NPR-A and Stimulates eNOS Gene Expression in Rat IMCD Cells Hypertension, March 1, 2003; 41(3): 675 - 681. [Abstract] [Full Text] [PDF]

				S. Chen, L. Cao, H. D. Intengan, M. Humphreys, and D. G. Gardner Osmoregulation of Endothelial Nitric-oxide Synthase Gene Expression in Inner Medullary Collecting Duct Cells. ROLE IN ACTIVATION OF THE TYPE A NATRIURETIC PEPTIDE RECEPTOR J. Biol. Chem., August 30, 2002; 277(36): 32498 - 32504. [Abstract] [Full Text] [PDF]

				S. Chen and D. G. Gardner Osmoregulation of Natriuretic Peptide Receptor Signaling in Inner Medullary Collecting Duct. A REQUIREMENT FOR p38 MAPK J. Biol. Chem., February 15, 2002; 277(8): 6037 - 6043. [Abstract] [Full Text] [PDF]

				L. Cao, S. C. Chen, T. Cheng, M. H. Humphreys, and D. G. Gardner Ligand-dependent regulation of NPR-A gene expression in inner medullary collecting duct cells Am J Physiol Renal Physiol, July 1, 1998; 275(1): F119 - F125. [Abstract] [Full Text] [PDF]

				M. E. M. Castano, J. P. Schanstra, C. Hirtz, J. B. Pesquero, C. Pecher, J.-P. Girolami, and J.-L. Bascands B2 kinin receptor upregulation by cAMP is associated with BK-induced PGE2 production in rat mesangial cells Am J Physiol Renal Physiol, March 1, 1998; 274(3): F532 - F540. [Abstract] [Full Text] [PDF]

				L. A Brown, R. A.D Rutherford, D. J.R Nunez, John Wharton, D. G Lowe, and M. R Wilkins Downregulation of natriuretic peptide C-receptor protein in the hypertrophied ventricle of the aortovenocaval fistula rat Cardiovasc Res, December 1, 1997; 36(3): 363 - 371. [Abstract] [Full Text] [PDF]

				D. W. Zlock, L. Cao, J. Wu, and D. G. Gardner Thrombin Inhibits Atrial Natriuretic Peptide Receptor Activity in Cultured Bovine Endothelial Cells Hypertension, January 1, 1997; 29(1): 83 - 90. [Abstract] [Full Text]

				L. Cao, J. Wu, and D. G. Gardner Atrial Natriuretic Peptide Suppresses the Transcription of Its Guanylyl Cyclase-linked Receptor J. Biol. Chem., October 20, 1995; 270(42): 24891 - 24897. [Abstract] [Full Text] [PDF]